Actually, it doesn't take them that long. It only takes the competitor 2 weeks to create another lot. However, I believe it will take two months to get a couple hundred doses.
However, as a patient, I'd prefer to take TKM-ebola since it has a better success rate in the pre clinicals. Substantially better.
I'm not sure why the two missionaries chose to use the competitors therapy other than they wanted to stay with a company in the US since they are from the US? But, it wasn't the logical choice based on pre clinical results.
The FDA has now given the ok for TKMR to treat diseased patients with TKM-ebola. We now wait to see what WHO and the international community decides is the best route. My bet is that multiple companies end up treating sick ebola patients. But, TKMR is set up to get in there first. They are the closest to being ready since they are the only company to have already started a phase I safety trial in healthy humans.
The trial was put on hold until some questions could be resolved, but, that was changed to a partial hold allowing the treatment of diseased patients.
There may in fact be a dip if many misunderstand and actually think the competitor has a cure. But, that won't last long as reality sets in.
We don't know if TKM-ebola works as well in humans as it did in primates, but, we do know it works better in the primates than the competitors therapy did!
News 
Market Data 
Discover 
